Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - South Africa

South Africa

According to projections, the Neoplasm Treatment market in South Africa is expected to achieve a revenue of €0.94bn by the year 2024.
Furthermore, it is anticipated that this sector will experience a compound annual growth rate (CAGR) of 3.38% between 2024 and 2029, leading to a market volume of €1.11bn by 2029.
When comparing these figures on a global scale, it is worth noting that United States is projected to generate the highest revenue in this market, with an estimated amount of €83.98bn in 2024.
South Africa is experiencing a growing demand for advanced neoplasm treatment options to address the increasing prevalence of cancer in the country.

Key regions: Europe, Canada, Brazil, United States, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.